Get to Know Our Quantitative Sciences Team: The Brains Behind Our Data (Zhongdi Chu)


Verana Health

Verana Health has a team of more than 30 quantitative scientists who work toward the goal of producing high-quality, data-driven insights that can help inform research and improve patient outcomes. 

In this blog series, we invite you to “Get to Know Our Quantitative Sciences Team: The Brains Behind Our Data.” Read more about Zhongdi Chu, Quantitative Sciences senior manager.

Q: How would you explain your role? 

A: I lead our Data Development group within the Quantitative Sciences team. In my role, I work with a cross-functional team to create fit-for-purpose Qdata® modules using natural language processing (NLP), computer vision (CV), and artificial intelligence/machine learning (AI/ML) techniques.   

Q: What attracted you to the Quantitative Sciences field? 

A: I appreciate the ability to explain things with numbers. I find human biology fascinating and I enjoy being able to represent biology mathematically, so that we can make comparisons and draw conclusions. The quantitative sciences field seems like the perfect field to make a human impact and maintain logic and order.  

Q: What attracted you to Verana Health? 

A: Verana Health is really exciting to me because of the access to an ocean of data. There are ample opportunities to explore, experiment, innovate and execute using multiple state-of-the-art techniques. It’s also encouraging to know that we make a positive impact to society by helping patients gain access to the treatments they need, either through supporting clinical trials recruitment, post-marketing label expansion, or other real-world evidence (RWE) studies on safety and efficacy. 

Q: What inspires you to do this work? 

A: The potential we have to further human understanding of certain diseases, as well as to improve patient outcomes, is what inspires me to do this work.

Q: What is the most rewarding part of your job? 

A: The most rewarding part of my job is delivering meaningful results using advanced techniques in a cross-functional setting. For example, we recently launched our Qdata Geographic Atrophy module using a variety of AI/ML techniques. Through Qdata Geographic Atrophy, we are able to understand disease under-diagnosis and under-coding with advanced NLP/CV ML algorithms. We are also able to track real-world geographic atrophy growth rate, the exact endpoint used in clinical trials. 

Q: What advancements do you see in your field in the next 5 years? 

A: In the next 5 years, I see AI/ML being widely adopted and leveraged in clinical settings at the point of care. This will also enable RWE to be more widely leveraged in regulatory decision-making processes.

When she’s not using advanced techniques to create insights, Zhongdi enjoys hiking in her spare time.

Verana Health Logo

Let's Accelerate Research Together

To learn more about Verana Health, please fill out the information below and our team will follow up with you as soon as possible.